Protocol No.: Amorcyte Study-002; A Prospective Randomized Double Blinded Placebo Controlled Phase II Trial of Intra-coronary Infusion of AMR-001, a Bone Marrow Derived Autologous CD34+ Selected Cell Product, in Patients with Acute Myocardial Infarction

  • Fujise, Kenichi, (PI)

Project: Other project

Project Details

Funding

  • Amorcyte Incorporated: $158,331.50